https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Prevalence and relationship between gastrointestinal symptoms among individuals of different body mass index: a population-based study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23948 Wed 23 Feb 2022 16:07:08 AEDT ]]> Operative management of acute abdomen after bariatric surgery in the emergency setting: the OBA guidelines https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53329 4 weeks after surgical procedure) following sleeve gastrectomy and Roux-en-Y gastric bypass and their anatomy leads to a focused management in the emergency setting with good outcomes and decreased morbidity and mortality rates. A close collaboration between emergency surgeons, radiologists, endoscopists, and anesthesiologists is mandatory in the management of this group of patients in the emergency setting.]]> Wed 22 Nov 2023 10:12:43 AEDT ]]> Factors Associated With Placebo Treatment Response in Functional Dyspepsia Clinical Trials https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50841 Wed 09 Aug 2023 09:10:43 AEST ]]> Functional dyspepsia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41420 Wed 03 Aug 2022 11:59:24 AEST ]]> Assessment and management of older patients with abdominal pain in the emergency department https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54337 Tue 20 Feb 2024 16:12:05 AEDT ]]> Somatic symptom severity association with healthcare utilization and costs in surgical inpatients with an episode of abdominal pain https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51852 Thu 21 Sep 2023 09:34:04 AEST ]]> Food and functional dyspepsia: a systematic review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36114 Thu 13 Feb 2020 09:38:08 AEDT ]]> Prospective diary evaluation of unexplained abdominal pain and bowel dysfunction: a population-based colonoscopy study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:12383 Sat 24 Mar 2018 08:18:00 AEDT ]]> Irritable bowel syndrome: rational therapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13490 Sat 24 Mar 2018 08:16:45 AEDT ]]> Influence of posture and body type on the experience of exercise-related transient abdominal pain https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10572 Sat 24 Mar 2018 08:10:45 AEDT ]]> Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19979 Sat 24 Mar 2018 07:50:57 AEDT ]]> EMG activity is not elevated during exercise-related transient abdominal pain https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:5147 Sat 24 Mar 2018 07:49:40 AEDT ]]> Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27609 3-fold more likely to report adequate relief than those given placebo (odds ratio = 3.1; 95% confidence interval: 1.1-9.0). Neither amitriptyline nor escitalopram appeared to affect GE or meal-induced satiety after the 10-week period in any group. Subjects with delayed GE were less likely to report adequate relief than subjects with normal GE (odds ratio = 0.4; 95% confidence interval: 0.2-0.8). Both antidepressants improved overall quality of life. Conclusions Amitriptyline, but not escitalopram, appears to benefit some patients with FD, particularly those with ulcer-like (painful) FD. Patients with delayed GE do not respond to these drugs.]]> Sat 24 Mar 2018 07:39:41 AEDT ]]> Exercise-related transient abdominal pain (ETAP) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26778 Sat 24 Mar 2018 07:36:23 AEDT ]]> Using the Patient Health Questionnaire to estimate prevalence and gender differences of somatic symptoms and psychological co-morbidity in a secondary inpatient population with abdominal pain https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44801 Mon 24 Oct 2022 09:24:27 AEDT ]]> Human intestinal spirochetosis, irritable bowel syndrome, and colonic polyps: A systematic review and meta-analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50098 Mon 17 Jul 2023 11:05:36 AEST ]]> Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47763 P = 0.008). Compared with placebo, the overall IBS BSS severity score was lower in the pregabalin arm (26 vs 42, P = 0.009). Differences were observed for the diarrhoea‐BSS and bloating‐BSS scores (P = 0.049 and 0.016, respectively). No differences between groups were seen for constipation‐BSS scores. Adequate relief was not different between the two arms (46% vs 36%, P = 0.35). 63% pregabalin vs 45% placebo had a change in pain score ≥30 at week 12 from baseline (P = 0.10). Post‐treatment IBS‐QoL scores did not differ between groups. Conclusion: This trial suggests that pregabalin may be beneficial for IBS abdominal pain, bloating and diarrhoea.]]> Fri 27 Jan 2023 11:07:17 AEDT ]]>